Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS
Title:
Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS
Author:
Ryabov, V. Xu, Q. Schmitt, N. Streuer, A. Ge, G. Bolanos, L. Wunderlich, M. Jann, J.-C. Wein, A. Altrock, E. Mukherjee, S. Ali, A.M. Rapp, F. Nowak, V. Weimer, N. Obländer, J. Palme, I. Göl, M. Jawhar, A. Darwich, A. Wuchter, P. Weiss, C. Raza, A. Foulks, J.M. Starczynowski, D.T. Yang, F.-C. Metzgeroth, G. Steiner, L. Jawhar, M. Hofmann, W.-K. Nowak, D.